Overview

Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions

Status:
Completed

Trial end date:
2013-01-01

Target enrollment:

Participant gender:

Summary

To assess the bioequivalence of Test oral formulation of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET versus Reference ANTADYS®100 mg Comprimé Pelliculé & PEPCID® (Famotidine) 20mg Tablets, USP.

Phase:

Phase 1

Details

Lead Sponsor:

Pharmaceutical Research Unit, Jordan

Treatments:

Famotidine
Flurbiprofen